Elexacaftor
Showing 1 - 25 of 59
Elexacaftor/Tezacaftor/Ivacaftor, in Cystic Fibrosis and Caloric
Completed
- Cystic Fibrosis
- nutritional intake questionnaire
-
Bordeaux, France
- +2 more
Oct 2, 2023
Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor
Enrolling by invitation
- Cystic Fibrosis
-
Denver, Colorado
- +1 more
Apr 7, 2023
CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor -
Recruiting
- Cystic Fibrosis
- Elexacaftor / Ivacaftor / Tezacaftor
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlange, Department of Pediatrics
Oct 7, 2022
Cystic Fibrosis (CF), CFTR Gene Mutation Trial (12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause)
Not yet recruiting
- Cystic Fibrosis (CF)
- CFTR Gene Mutation
- 12 hours ETI pause
- +2 more
- (no location specified)
Apr 17, 2023
Drug Drug Interaction Trial in Los Angeles (Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg], Rifabutin
Recruiting
- Drug Drug Interaction
- Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
- Rifabutin 300mg
-
Los Angeles, CaliforniaUniversity of Southern California
May 9, 2022
Cystic Fibrosis Trial in France (Sample collection)
Recruiting
- Cystic Fibrosis
- Sample collection
-
Bordeaux, France
- +14 more
Jul 7, 2023
Trikafta Exercise Study in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
- Lung Diseases
-
Vancouver, British Columbia, CanadaUBC Centre for Heart Lung Innovation, St. Paul's Hospital
Mar 3, 2022
Non-cystic Fibrosis Bronchiectasis Trial in Atlanta (Trikafta)
Recruiting
- Non-cystic Fibrosis Bronchiectasis
-
Atlanta, GeorgiaThe Emory Clinic
Feb 15, 2023
Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior
Active, not recruiting
- Cystic Fibrosis
- Elexacaftor / Ivacaftor / Tezacaftor
-
Nottingham, Nottinghamshire, United KingdomQueen's Medical Centre
Jan 24, 2023
Trikafta/Kaftrio and Pseudomonas Aeruginosa
Recruiting
- Cystic Fibrosis
-
Milan, Italy
- +1 more
Jan 9, 2023
Respiratory Symptoms and Spirometry During ETI Treatment in
Active, not recruiting
- Cystic Fibrosis
- Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening
-
Liège, BelgiumLebecque
Oct 25, 2022
Impact of Triple Combination CFTR Therapy on Sinus Disease.
Recruiting
- Cystic Fibrosis
- Elexacaftor-tezacaftor-ivacaftor exposure
-
Denver, ColoradoNational Jewish Health
Mar 9, 2021
Cystic Fibrosis Transmembrane Regulator Biomarker Study to
Recruiting
- Cystic Fibrosis
- Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor
-
Berlin, Germany
- +3 more
Apr 1, 2022